Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin 15 receptor beta subunit (IL15RB), also known as the interleukin 2 receptor beta chain (IL2RB) and CD122, is a type I membrane protein and a shared signaling component for both the interleukin 2 (IL-2) and interleukin 15 (IL-15) receptors. It plays a crucial role in mediating immune responses, particularly those involving T cells and natural killer (NK) cells. Activation via this receptor complex increases proliferation, especially among CD8+ effector T-cells and NK-cells, key players in anti-tumor immunity and viral defense responses. The receptor exists as part of heterotrimeric complexes, using distinct alpha chains for cytokine specificity but the same beta (IL15RB/CD122) and gamma common (γc) chains for signal transduction.
Agonist or antagonist modulation of IL-2 and IL-15 signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 15 Receptor Beta Subunit (IL15RB).